Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, Niels Jongs, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, William G Herrington, Silvio E Inzucchi, Meg J Jardine, Chih-Chin Liu, Kenneth W Mahaffey, Darren K McGuire, John J V McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Marc S Sabatine, Scott D Solomon, Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C Wheeler, Stephen D Wiviott, Faiez Zannad, Hiddo J L Heerspink

Open source

DOI
10.1016/s2213-8587(24)00155-4
Published
2024-08
Container
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-24-00155-4,
  title = {Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials},
  author = {Ellen M Apperloo and Brendon L Neuen and Robert A Fletcher and Niels Jongs and Stefan D Anker and Deepak L Bhatt and Javed Butler and David Z I Cherney and William G Herrington and Silvio E Inzucchi and Meg J Jardine and Chih-Chin Liu and Kenneth W Mahaffey and Darren K McGuire and John J V McMurray and Bruce Neal and Milton Packer and Vlado Perkovic and Marc S Sabatine and Scott D Solomon and Natalie Staplin and Michael Szarek and Muthiah Vaduganathan and Christoph Wanner and David C Wheeler and Stephen D Wiviott and Faiez Zannad and Hiddo J L Heerspink},
  year = {2024},
  journal = {The Lancet Diabetes \& Endocrinology},
  doi = {10.1016/s2213-8587(24)00155-4},
  url = {https://doi.org/10.1016/s2213-8587(24)00155-4}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
AU  - Ellen M Apperloo
AU  - Brendon L Neuen
AU  - Robert A Fletcher
AU  - Niels Jongs
AU  - Stefan D Anker
AU  - Deepak L Bhatt
AU  - Javed Butler
AU  - David Z I Cherney
AU  - William G Herrington
AU  - Silvio E Inzucchi
AU  - Meg J Jardine
AU  - Chih-Chin Liu
AU  - Kenneth W Mahaffey
AU  - Darren K McGuire
AU  - John J V McMurray
AU  - Bruce Neal
AU  - Milton Packer
AU  - Vlado Perkovic
AU  - Marc S Sabatine
AU  - Scott D Solomon
AU  - Natalie Staplin
AU  - Michael Szarek
AU  - Muthiah Vaduganathan
AU  - Christoph Wanner
AU  - David C Wheeler
AU  - Stephen D Wiviott
AU  - Faiez Zannad
AU  - Hiddo J L Heerspink
PY  - 2024
JO  - The Lancet Diabetes & Endocrinology
DO  - 10.1016/s2213-8587(24)00155-4
UR  - https://doi.org/10.1016/s2213-8587(24)00155-4
ER  - 

APA

Apperloo, E. M., Neuen, B. L., Fletcher, R. A., Jongs, N., Anker, S. D., Bhatt, D. L., Butler, J., Cherney, D. Z. I., Herrington, W. G., Inzucchi, S. E., Jardine, M. J., Liu, C., Mahaffey, K. W., McGuire, D. K., McMurray, J. J. V., Neal, B., Packer, M., Perkovic, V., Sabatine, M. S., Solomon, S. D., Staplin, N., Szarek, M., Vaduganathan, M., Wanner, C., Wheeler, D. C., Wiviott, S. D., Zannad, F., & Heerspink, H. J. L. (2024). Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(24)00155-4

Source records